Pharmaceuticals
-
Gene variation protects against diabetes
A gene linked to type 2 diabetes may offer clues to new therapies, British researchers say. Read more
-
Two hormones key to prostate cancer risk
Men have an increased risk of developing prostate cancer if their blood has high levels of free testosterone and a growth hormone, a conference hears today. Read more
-
Peanut allergy immunotherapy not a cure
Immunotherapy for peanut allergy can provide some protection – but does not offer a permanent cure, according to research published today. Read more
-
Hope for Alzheimer’s treatment opportunity
Scientists working on progressive neurodegeneration diseases have found that some of the changes could be halted during an “under-appreciated time window”. Read more
-
Caution urged around antibiotic threat
The language used to describe antimicrobial resistance is counterproductive and unlikely to cut the overuse, experts say today. Read more
-
Blood pressure drugs best taken at bedtime?
Hypertensive patients can have better control of their condition, and lower risk of adverse events by taking medications last thing at night rather than in the morning, researchers report today. Read more
-
Antibiotics resistance doubles in 20 years
Resistance to antibiotics used for treating H. Pylori infections has more than doubled in 20 years, a European conference has heard. Read more
-
Cannabidiol trial for Parkinson’s-related psychosis
A £1.2 million phase II trial is to begin early next year into the effectiveness of cannabidiol in people with Parkinson’s-related psychosis. Read more
-
Study challenges paclitaxel coating fears
There is no evidence of increased mortality risk from the use of paclitaxel coated devices, according to an analysis published today. Read more
-
Antimicrobial resistance battle faltering
The battle against antimicrobial resistance is faltering in the world’s poorest countries, a think-tank has warned. Read more
